MLJ CONSULTANCY LLC stands out by offering specialized online consulting that combines deep expertise in HIPAA compliance with practical guidance on AI integration, cybersecurity, revenue cycle management, data analytics, and project management, all tailored specifically for the healthcare sector, with live multimodal trustworthy AI support.
The federal government announced a final rule on February 8, 2024, updating the Confidentiality of Substance Use Disorder (SUD) Patient Records regulations under 42 CFR Part 2. These changes aim to improve the sharing of patient information while maintaining strong privacy protections. This post explains the key modifications, how they align with other healthcare laws, and what they mean for patients, providers, and the healthcare system. 42 CFR Part 2 Key Modifications to 42
Protecting the privacy of individuals receiving treatment for Substance Use Disorder (SUD) has always been a critical concern. Recent changes brought by the CARES Act and the U.S. Department of Health and Human Services’ (HHS) proposed rulemaking aim to update and clarify how SUD patient records are handled. These changes seek to balance patient privacy with the need for effective care coordination and public health efforts. This article explains the key amendments to section
The integration of Artificial Intelligence (AI) into healthcare has transformed patient care, diagnostics, and operational efficiency. However, this rapid progress brings significant concerns about the privacy of sensitive patient information. As healthcare organizations increasingly adopt AI-driven solutions, balancing the benefits of AI with robust patient privacy measures is essential.